OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
HLA-G and IL-10 expression in human cancer—different stories with the same message
Mirjana Urosevic, Reinhard Dummer
Seminars in Cancer Biology (2003) Vol. 13, Iss. 5, pp. 337-342
Closed Access | Times Cited: 104
Mirjana Urosevic, Reinhard Dummer
Seminars in Cancer Biology (2003) Vol. 13, Iss. 5, pp. 337-342
Closed Access | Times Cited: 104
Showing 1-25 of 104 citing articles:
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim, Manabu Emi, Kazuaki Tanabe
Immunology (2007) Vol. 121, Iss. 1, pp. 1-14
Open Access | Times Cited: 1021
Ryungsa Kim, Manabu Emi, Kazuaki Tanabe
Immunology (2007) Vol. 121, Iss. 1, pp. 1-14
Open Access | Times Cited: 1021
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
Cunren Liu, Shaohua Yu, Kurt R. Zinn, et al.
The Journal of Immunology (2006) Vol. 176, Iss. 3, pp. 1375-1385
Open Access | Times Cited: 481
Cunren Liu, Shaohua Yu, Kurt R. Zinn, et al.
The Journal of Immunology (2006) Vol. 176, Iss. 3, pp. 1375-1385
Open Access | Times Cited: 481
Interleukin-10 and the immune response against cancer: a counterpoint
Simone Mocellin, Francesco M. Marincola, Howard A. Young
Journal of Leukocyte Biology (2005) Vol. 78, Iss. 5, pp. 1043-1051
Closed Access | Times Cited: 394
Simone Mocellin, Francesco M. Marincola, Howard A. Young
Journal of Leukocyte Biology (2005) Vol. 78, Iss. 5, pp. 1043-1051
Closed Access | Times Cited: 394
HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
Takami Sato, Mizue Terai, Yutaka Tamura, et al.
Immunologic Research (2011) Vol. 51, Iss. 2-3, pp. 170-182
Closed Access | Times Cited: 249
Takami Sato, Mizue Terai, Yutaka Tamura, et al.
Immunologic Research (2011) Vol. 51, Iss. 2-3, pp. 170-182
Closed Access | Times Cited: 249
Current status of interleukin-10 and regulatory T-cells in cancer
Kristen L. Dennis, Nichole R. Blatner, Fotini Gounari, et al.
Current Opinion in Oncology (2013) Vol. 25, Iss. 6, pp. 637-645
Open Access | Times Cited: 249
Kristen L. Dennis, Nichole R. Blatner, Fotini Gounari, et al.
Current Opinion in Oncology (2013) Vol. 25, Iss. 6, pp. 637-645
Open Access | Times Cited: 249
Aging, Longevity, Inflammation, and Cancer
Calogero Caruso, Domenico Lio, Luca Cavallone, et al.
Annals of the New York Academy of Sciences (2004) Vol. 1028, Iss. 1, pp. 1-13
Closed Access | Times Cited: 219
Calogero Caruso, Domenico Lio, Luca Cavallone, et al.
Annals of the New York Academy of Sciences (2004) Vol. 1028, Iss. 1, pp. 1-13
Closed Access | Times Cited: 219
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Cailin Moira Wilke, Shuang Wei, Lin Wang, et al.
Cancer Immunology Immunotherapy (2011) Vol. 60, Iss. 11, pp. 1529-1541
Open Access | Times Cited: 129
Cailin Moira Wilke, Shuang Wei, Lin Wang, et al.
Cancer Immunology Immunotherapy (2011) Vol. 60, Iss. 11, pp. 1529-1541
Open Access | Times Cited: 129
The Dual Role of HLA-G in Cancer
Nathalie Rouas‐Freiss, Philippe Moreau, Joël LeMaoult, et al.
Journal of Immunology Research (2014) Vol. 2014, pp. 1-10
Open Access | Times Cited: 106
Nathalie Rouas‐Freiss, Philippe Moreau, Joël LeMaoult, et al.
Journal of Immunology Research (2014) Vol. 2014, pp. 1-10
Open Access | Times Cited: 106
Similarities Between Embryo Development and Cancer Process Suggest New Strategies for Research and Therapy of Tumors: A New Point of View
Giovanni Manzo
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 97
Giovanni Manzo
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 97
Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani, et al.
Open Biology (2020) Vol. 10, Iss. 9
Open Access | Times Cited: 93
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani, et al.
Open Biology (2020) Vol. 10, Iss. 9
Open Access | Times Cited: 93
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia
Holger Nückel, Vera Rebmann, Jan Dürig, et al.
Blood (2004) Vol. 105, Iss. 4, pp. 1694-1698
Open Access | Times Cited: 162
Holger Nückel, Vera Rebmann, Jan Dürig, et al.
Blood (2004) Vol. 105, Iss. 4, pp. 1694-1698
Open Access | Times Cited: 162
Tumor immune escape mediated by indoleamine 2,3-dioxygenase
Μαρία Ζαμανάκου, Anastasios E. Germenis, Vaios Karanikas
Immunology Letters (2007) Vol. 111, Iss. 2, pp. 69-75
Closed Access | Times Cited: 110
Μαρία Ζαμανάκου, Anastasios E. Germenis, Vaios Karanikas
Immunology Letters (2007) Vol. 111, Iss. 2, pp. 69-75
Closed Access | Times Cited: 110
Non‐classical transcriptional regulation of HLA‐G: an update
Philippe Moreau, Sébastien Flajollet, Edgardo D. Carosella
Journal of Cellular and Molecular Medicine (2009) Vol. 13, Iss. 9b, pp. 2973-2989
Open Access | Times Cited: 103
Philippe Moreau, Sébastien Flajollet, Edgardo D. Carosella
Journal of Cellular and Molecular Medicine (2009) Vol. 13, Iss. 9b, pp. 2973-2989
Open Access | Times Cited: 103
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
HLA-G Expressing Immune Cells in Immune Mediated Diseases
Paola Contini, Giuseppe Murdaca, Francesco Puppo, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 51
Paola Contini, Giuseppe Murdaca, Francesco Puppo, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 51
Immunotherapy for lung cancer
Girshani Sathish, L.K. Monavarshini, Keerthi Sundaram, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155104-155104
Closed Access | Times Cited: 6
Girshani Sathish, L.K. Monavarshini, Keerthi Sundaram, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155104-155104
Closed Access | Times Cited: 6
Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses
Nathalie Rouas‐Freiss, Philippe Moreau, Catherine Menier, et al.
Seminars in Cancer Biology (2007) Vol. 17, Iss. 6, pp. 413-421
Closed Access | Times Cited: 100
Nathalie Rouas‐Freiss, Philippe Moreau, Catherine Menier, et al.
Seminars in Cancer Biology (2007) Vol. 17, Iss. 6, pp. 413-421
Closed Access | Times Cited: 100
TNF‐α, TNF‐β, IL‐6, and IL‐10 Polymorphisms in Patients with Lung Cancer
Carola Seifart, Alexandra Plagens, Astrid Dempfle, et al.
Disease Markers (2005) Vol. 21, Iss. 3, pp. 157-165
Open Access | Times Cited: 96
Carola Seifart, Alexandra Plagens, Astrid Dempfle, et al.
Disease Markers (2005) Vol. 21, Iss. 3, pp. 157-165
Open Access | Times Cited: 96
Human Leukocyte Antigen–G and Cancer Immunoediting
Mirjana Urosevic, Reinhard Dummer
Cancer Research (2008) Vol. 68, Iss. 3, pp. 627-630
Open Access | Times Cited: 95
Mirjana Urosevic, Reinhard Dummer
Cancer Research (2008) Vol. 68, Iss. 3, pp. 627-630
Open Access | Times Cited: 95
Aberrant human leucocyte antigen‐G expression and its clinical relevance in hepatocellular carcinoma
Aifen Lin, H.‐X. Chen, Chengsong Zhu, et al.
Journal of Cellular and Molecular Medicine (2009) Vol. 14, Iss. 8, pp. 2162-2171
Open Access | Times Cited: 85
Aifen Lin, H.‐X. Chen, Chengsong Zhu, et al.
Journal of Cellular and Molecular Medicine (2009) Vol. 14, Iss. 8, pp. 2162-2171
Open Access | Times Cited: 85
Emerging topics and new perspectives on HLA-G
Enrico Fainardi, Massimiliano Castellazzi, Marina Stignani, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 433-451
Closed Access | Times Cited: 77
Enrico Fainardi, Massimiliano Castellazzi, Marina Stignani, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 433-451
Closed Access | Times Cited: 77
Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis
Laurence Amiot, Nicolas Vu, Michel Rauch, et al.
Journal of Hepatology (2013) Vol. 60, Iss. 2, pp. 245-252
Open Access | Times Cited: 70
Laurence Amiot, Nicolas Vu, Michel Rauch, et al.
Journal of Hepatology (2013) Vol. 60, Iss. 2, pp. 245-252
Open Access | Times Cited: 70
HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
Marianne J. Rutten, Frederike Dijk, C. Dilara Savci-Heijink, et al.
Journal of Immunology Research (2014) Vol. 2014, pp. 1-11
Open Access | Times Cited: 54
Marianne J. Rutten, Frederike Dijk, C. Dilara Savci-Heijink, et al.
Journal of Immunology Research (2014) Vol. 2014, pp. 1-11
Open Access | Times Cited: 54
